Dec. 10 (UPI) -- The Food and Drug Administration's regulatory vaccines committee on Thursday voted to recommend the COVID-19 vaccine developed by Pfizer and BioNTech for emergency use authorization.
The vote by the FDA Vaccines and Related Biological Products Advisory Committee doesn't mean the vaccine gets immediate approval by the FDA. That decision will be made at a future time that has yet to be announced.